NCT04462471 2025-09-08Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed8 enrolled 8 charts
NCT03735628 2023-10-06An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid TumorsBayerPhase 1 Completed16 enrolled